Molecular and Clinicopathological Analysis of Ovarian Carcinomas with and Without Microsatellite Instability

Anticancer Research

Volumn 24, Issue 1, 2004, Pages 361-369

  Dellas, Athanassios ^a,c   Puhl, Alex ^a   Schraml, Peter ^a   Thomke, Sabine E ^a   Rüschoff, Josef ^b   Mihatsch, Michael J ^a   Moch, Holger ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b KLINIKUM KASSEL   (Germany)

^c NONE   (Switzerland)

Author keywords

Genomic aberrations; Microsatellite instability; Mismatch repair; Ovarian carcinoma

Indexed keywords

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHROMOSOME 5; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DINUCLEOTIDE REPEAT; EARLY CANCER; FEMALE; FLUORESCENCE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; MICROSATELLITE MARKER; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

BASE PAIR MISMATCH; CARRIER PROTEINS; DNA REPAIR; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; GENE DOSAGE; GENOMIC INSTABILITY; HUMANS; MICROSATELLITE REPEATS; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NEOPLASM STAGING; NUCLEAR PROTEINS; NUCLEIC ACID HYBRIDIZATION; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS; SURVIVAL RATE;

EID: 1442277058     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. DiSaia PJ and Creasman WT: Epithelial ovarian cancer. Incidence, epidemiology, and etiology. In: Clinical Gynecologic Oncology (Creasman WT, eds), 6th edition. St. Louis, Missouri, Mosby, Inc., 2002, pp. 289-350.
2. Zaloudek C: The ovary. In: Pathology in Gynecology and Obstetrics (Silverberg SG, eds), 4th edition. Philadelphia, JB Lippincott Company, 1994, pp. 330-334.
3. Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, Lee J, Lillie J and Smith DI: Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res 62: 262-270, 2002.
4. Loeb KR and Loeb LA: Significance of multiple mutations in cancer. Carcinogenesis 21: 379-385, 2000.
5. Perucho M: Cancer of the microsatellite mutator phenotype. Biol Chem 377: 675-684, 1996.
6. Heinen CD, Wilson T, Mazurek A, Berardini M, Butz C and Fishel R: HNPCC mutations in hMSH2 result in reduced hMSH2-hMSH6 molecular switch functions. Cancer Cell 1: 469-478, 2002.
7. Fishel R: The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis. Cancer Res 61: 7369-7374, 2001.
8. Acharya S, Wilson T, Gradia S, Kane MF, Guerrette S, Marsischky GT, Kolodner R and Fishel R: hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. Proc Natl Acad Sci USA 93: 13629-13634, 1996.
9. Peltomäki P: DNA mismatch repair and cancer. Mutation Res 488: 77-85, 2001.
10. Kolodner RD and Marsischky GT: Eukaryotic mismatch repair. Current Opinion Gen Dev 9: 89-96, 1999.
11. Jiricny J and Nyström-Lahti M: Mismatch repair defects in cancer. Current Opinion Gen Dev 10: 157-161, 2000.
12. Perucho M: Microsatellite instability: the mutator that mutates the other mutator. Nat Med 2: 630-631, 1996.
13. Lynch HT: Hereditary nonpolyposis colorectal cancer (HNPCC). Cytogenet Cell Genet 86: 130-135, 1999.
14. Lynch HT, Casey MJ, Lynch J, White TE and Godwin AK: Genetics and ovarian carcinoma. Semin Oncol 25: 265-280, 1998.
15. Watson P, Butzow R, Lynch HT, Mecklin JP, Jarvinen HJ, Vasen HF, Madlensky L, Fidalgo P and Bernstein I: The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 82: 223-228, 2001.
16. Atkin NB: Microsatellite instability. Cytogenet Cell Genet 92: 177-181, 2001.
17. Sood AK, Holmes R, Hendrix MJ and Buller RE: Application of the National Cancer Institute international criteria for determination of microsatellite instability in ovarian cancer. Cancer Res 61: 4371-4374, 2001.
18. Buller RE, Shahin MS, Holmes RW, Hatterman M, Kirby PA and Sood AK: p53 mutations and microsatellite instability in ovarian cancer: Yin and yang. Am J Obstet Gynecol 184: 891-902, 2001.
19. Allen HJ, DiCioccio RA, Hohmann P, Piver MS and Tworek H: Microsatellite instability in ovarian and other pelvic carcinomas. Cancer Genet Cytogenet 117: 163-166, 2000.
20. Gras E, Catasus L, Arguelles R, Moreno-Bueno G, Palacios J, Gamallo C, Matias-Guiu X and Prat J: Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 92: 2829-2836, 2001.
21. Alvi AJ, Rader JS, Broggini M, Latif F and Maher ER: Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer. Mol Pathol 54: 240-243, 2001.
22. Arzimanoglou, II, Lallas T, Osborne M, Barber H and Gilbert F: Microsatellite instability differences between familial and sporadic ovarian cancers. Carcinogenesis 17: 1799-1804, 1996.
23. Sood AK and Buller RE: Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. Oncogene 13: 2499-2504, 1996.
24. Lawes DA, SenGupta S and Boulos PB: The clinical importance and prognostic implications of microsatellite instability in sporadic cancer. Eur J Surg Oncol 29: 201-212, 2003.
25. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258: 818-821, 1992.
26. Kallioniemi OP, Kallioniemi A, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D: Comparative genomic hybridization: a rapid new method for detecting and mapping DNA amplification in tumors. Semin Cancer Biol 4: 41-46, 1993.
27. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D: Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243, 1994.
28. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH and Yarbro JW: AJCC Cancer Staging Manual, 5th edition. Philadelphia, Lippincott-Raven, 1997, p. 171-180.
29. Dodson MK, Hartmann LC, Cliby WA, DeLacey KA, Keeney GL, Ritland SR, Su JQ, Podratz KC and Jenkins RB: Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas. Cancer Res 53: 4456-4460, 1993.
30. Silverberg SG: Prognostic significance of pathologic features of ovarian carcinoma. Curr Top Pathol 78: 85-109, 1989.
31. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998.
32. Dietmaier W, Wallinger S, Bocker T, Kullmann F, Fishel R and Ruschoff J: Diagnostic microsatellite instability: definition and correlation with mismatch repair protein expression. Cancer Res 57: 4749-4756, 1997.
33. Dellas A, Torhorst J, Jiang F, Proffitt J, Schultheiss E, Holzgreve W, Sauter G, Mihatsch MJ and Moch H: Prognostic value of genomic alterations in invasive cervical squamous cell carcinoma of clinical stage IB detected by comparative genomic hybridization. Cancer Res 59: 3475-3479, 1999.
34. Dellas A, Torhorst J, Schultheiss E, Mihatsch MJ and Moch H: DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer. Clin Cancer Res 8: 1210-1216, 2002.
35. Ruschoff J, Bocker T, Schlegel J, Stumm G and Hofstaedter F: Microsatellite instability: new aspects in the carcinogenesis of colorectal carcinoma. Virchows Arch 426: 215-222, 1995.
36. Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl H, Ruschoff J and Hofstadter F: Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res 55: 6002-6005, 1995.
37. Gryfe R, Kim H, Hsieh ET, Aronson MD, Holowaty EJ, Bull SB, Redston M and Gallinger S: Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342: 69-77, 2000.
38. Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ, Witzig TE, Farr GH, Jr., Goldberg RM and Thibodeau SN: Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. J Natl Cancer Inst 91: 1295-1303, 1999.
39. Fujita M, Enomoto T, Yoshino K, Nomura T, Buzard GS, Inoue M and Okudaira Y: Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int J Cancer 64: 361-366, 1995.
40. Ohwada M, Suzuki M, Saga Y and Sato I: DNA replication errors are frequent in mucinous cystadenocarcinoma of the ovary. Cancer Genet Cytogenet 117: 61-65, 2000.
41. Haas CJ, Diebold J, Hirschmann A, Rohrbach H, Schmid S and Lohrs U: Microsatellite analysis in serous tumors of the ovary. Int J Gynecol Pathol 18: 158-162, 1999.
42. Iwabuchi H, Sakamoto M, Sakunaga H, Ma YY, Carcangiu ML, Pinkel D, Yang-Feng TL and Gray JW: Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res 55: 6172-6180, 1995.
43. Jass JR, Whitehall VL, Young J, Leggett B, Meltzer SJ, Matsubara N and Fishel R: Correspondence re: P. Laiho et al., Low-level microsatellite instability in most colorectal carcinomas. Cancer Res 62: 1166-1170, 2002.
44. Nakayama K, Takebayashi Y, Namiki T, Tamahashi N, Nakayama S, Uchida T, Miyazaki K and Fukumoto M: Comprehensive allelotype study of ovarian tumors of low malignant potential: potential differences in pathways between tumors with and without genetic predisposition to invasive carcinoma. Int J Cancer 94: 605-609, 2001.
45. Arzimanoglou, II, Hansen LL, Chong D, Li Z, Psaroudi MC, Dimitrakakis C, Jacovina AT, Shevchuk M, Reid L, Hajjar KA, Vassilaros S, Michalas S, Gilbert F, Chervenak FA and Barber HR: Frequent LOH at hMLH1, a highly variable SNP in hMSH3, and negligible coding instability in ovarian cancer. Anticancer Res 22: 969-975, 2002.
46. Guerrette S, Wilson T, Gradia S and Fishel R: Interactions of human hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations found in hereditary nonpolyposis colorectal cancer. Mol Cell Biol 18: 6616-6623, 1998.
47. Wijnen JT, Vasen HF, Khan PM, Zwinderman AH, van der Klift H, Mulder A, Tops C, Moller P and Fodde R: Clinical findings with implications for genetic testing in families with clustering of colorectal cancer. N Engl J Med 339: 511-518, 1998.
48. Orth K, Hung J, Gazdar A, Bowcock A, Mathis JM and Sambrook J: Genetic instability in human ovarian cancer cell lines. Proc Natl Acad Sci USA 91: 9495-9499, 1994.
49. Geisler JP, Geisler HE, Miller GA, Wiemann MC, Zhou Z and Crabtree W: Immunohistochemical staining of the mismatch repair gene, hMSH2, and survival in patients with ovarian carcinoma. Eur J Gynaecol Oncol 21: 237-240, 2000.
50. Ichikawa Y, Lemon SJ, Wang S, Franklin B, Watson P, Knezetic JA, Bewtra C and Lynch HT: Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members. Cancer Genet Cytogenet 112: 2-8, 1999.
51. Watanabe Y, Koi M, Hemmi H, Hoshai H and Noda K: A change in microsatellite instability caused by cisplatin-based chemotherapy of ovarian cancer. Br J Cancer 85: 1064-1069, 2001.
52. Hickey KP, Boyle KP, Jepps HM, Andrew AC, Buxton EJ and Burns PA: Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients. Br J Cancer 80: 1803-1808, 1999.
53. Tangir J, Loughridge NS, Berkowitz RS, Muto MG, Bell DA, Welch WR and Mok SC: Frequent microsatellite instability in epithelial borderline ovarian tumors. Cancer Res 56: 2501-2505, 1996.